| C04AE02 |
Nicergoline |
Nergolin |
Coated tablet |
10 |
mg |
90 |
Actavis Group PTC ehf., Исландия |
30 |
mg |
- |
22 |
0.70833 |
21.25 |
25% |
5.31 |
|
H36.0,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
НСР-1638/11.11.2013; НСР-15741/25.05.2018 |
02.07.2018 |
|
|
Активен |
2186 |
| C04AE02 |
Nicergoline |
NERGOLIN |
Coated tablet |
10 |
mg |
30 |
Actavis Group PTC ehf., Исландия |
30 |
mg |
- |
8.94 |
0.70833 |
7.08 |
25% |
1.77 |
|
H36.0,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 70/ 19.04.2010; НСР-15741/25.05.2018; НСР-19060/27.06.2019 |
02.08.2019 |
08.09.2012 |
|
Активен |
848 |
| C04AE02 |
Nicergoline |
SERMION |
Film coated tablet |
10 |
mg |
90 |
Pfizer Europe MA EEIG, Белгия |
30 |
mg |
- |
26.22 |
0.70833 |
21.25 |
25% |
5.31 |
|
H36.0,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 124/ 13.12.2010; КП-88/24.09.2014 и НСР-1158/13.09.2013 г.; Протокол №132/20.08.2015.; НСР-15219/09.03.2018; НСР-17196/09.11.2018 |
02.12.2018 |
08.09.2012 |
|
Активен |
3212 |
| C04AE02 |
Nicergoline |
SERMION |
Coated tablet |
10 |
mg |
50 |
Pfizer Enterprises SARL, Люксембург |
30 |
mg |
- |
14.94 |
0.733 |
12.22 |
25% |
3.05 |
|
H36.0,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8,I73.1 |
№ 24/31.07.2009
№35/21.08.2009
№40/27.08.2009; НСР-3599/23.05.2014; НСР-3711/06.06.2014 |
02.07.2014 |
08.09.2012 |
|
Заличен |
2829 |
| C04AE02 |
Nicergoline |
SERMION |
Film coated tablet |
10 |
mg |
30 |
Pfizer Europe MA EEIG, Белгия |
30 |
mg |
- |
9.66 |
0.70833 |
7.08 |
25% |
1.77 |
|
H36.0,I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 124/ 13.12.2010; НСР-15219/09.03.2018; НСР-17196/09.11.2018 |
02.12.2018 |
08.09.2012 |
|
Активен |
952 |
| C04AE02 |
Nicergoline |
SERMION |
Film coated tablet |
30 |
mg |
30 |
Pfizer Europe MA EEIG, Белгия |
30 |
mg |
- |
21.25 |
0.70833 |
21.25 |
25% |
5.31 |
|
I69.0,I69.1,I69.2,I69.3,I69.4,I69.8 |
№ 16/24.06.2009; № 35/21.08.2009; НСР-620/23.07.2013; НСР-7478/12.11.2015; НСР-10347/26.09.2016; НСР-17196/09.11.2018 |
02.12.2018 |
08.09.2012 |
|
Активен |
2012 |
| C04AX21 |
Naftidrofuryl |
C04AX21 Naftidrofuryl |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C04AX21 |
Naftidrofuryl |
Drosunal |
Coated tablet |
50 |
mg |
30 |
Актавис EАД, България |
600 |
mg |
- |
3.96 |
1.584 |
3.96 |
25% |
0.99 |
|
I69.3,I69.4,I69.8,I73.1 |
НСР-9751/14.07.2016 |
02.08.2016 |
08.09.2012 |
|
Заличен |
228 |
| C04AX21 |
Naftidrofuryl |
DUSODRIL |
Capsule, hard |
100 |
mg |
50 |
Merck Sante S.A.S, Франция |
600 |
mg |
- |
21.31 |
1.704 |
14.19 |
25% |
3.54 |
|
I73.1 |
НСР-7118/24.09.2015; НСР-16562/24.08.2018 |
02.10.2018 |
|
|
Активен |
4076 |
| C04AX21 |
Naftidrofuryl |
DUSODRIL |
Film coated tablet |
200 |
mg |
20 |
Merck Sante S.A.S, Франция |
600 |
mg |
- |
8.35 |
1.2525 |
8.35 |
25% |
2.09 |
|
I69.3,I69.4,I69.8,I73.1 |
НСР-2134/14.12.2013; НСР-7086/15.09.2015 |
16.10.2015 |
08.09.2012 |
|
Заличен |
2356 |
| C04AX21 |
Naftidrofuryl |
DUSODRIL |
Capsule, hard |
100 |
mg |
20 |
Merck Sante S.A.S, Франция |
600 |
mg |
- |
5.24 |
1.2525 |
4.17 |
25% |
1.04 |
|
I69.3,I69.4,I69.8,I73.1 |
НСР-2134/14.12.2013; НСР-6464/18.06.2015 |
16.07.2015 |
08.09.2012 |
|
Заличен |
2355 |
| C04AX21 |
Naftidrofuryl |
DUSOPHARM |
Film coated tablet |
50 |
mg |
30 |
Софарма АД, България |
600 |
mg |
- |
4.26 |
1.704 |
4.26 |
25% |
1.06 |
|
I69.3,I69.4,I69.8,I73.1 |
НСР-9314/16.05.2016; НСР-18408/05.04.2019 |
02.05.2019 |
08.09.2012 |
|
Активен |
499 |
| C07AA05 |
Propranolol |
C07AA05 Propranolol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AA05 |
Propranolol |
Propranolol Accord |
Film coated tablet |
40 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
160 |
mg |
- |
5.95 |
0.4272 |
3.2 |
50% |
1.6 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-12460/28.04.2017 |
02.06.2017 |
|
|
Активен |
1766 |
| C07AA05 |
Propranolol |
Propranolol Accord |
Tablet |
80 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
160 |
mg |
- |
29.1 |
0.4272 |
6.41 |
50% |
3.2 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
КЦРР-2741/20.03.2013 г.; НСР-8215/22.02.2016 |
02.04.2016 |
|
|
Заличен |
1767 |
| C07AA05 |
Propranolol |
Propranolol Accord |
Tablet |
40 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
160 |
mg |
- |
14.9 |
0.4272 |
3.2 |
50% |
1.6 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
КЦРР-2741/20.03.2013 г.; НСР-8214/22.02.2016 |
02.04.2016 |
|
|
Заличен |
1766 |
| C07AA05 |
Propranolol |
Propranolol Actavis |
Tablet |
20 |
mg |
50 |
Actavis Group PTC ehf., Исландия |
160 |
mg |
- |
3.06 |
0.4272 |
2.67 |
50% |
1.33 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-7081/09.09.2015 |
02.10.2015 |
|
|
Активен |
877 |
| C07AA05 |
Propranolol |
Propranolol Actavis |
Tablet |
40 |
mg |
50 |
Актавис EАД, България |
160 |
mg |
- |
5.34 |
0.4272 |
5.34 |
50% |
2.67 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-7081/09.09.2015 |
02.10.2015 |
|
|
Активен |
229 |
| C07AA05 |
Propranolol |
Propranolol Actavis |
Tablet |
20 |
mg |
50 |
Actavis Group PTC ehf., Исландия |
160 |
mg |
- |
3.06 |
0.2688 |
1.68 |
50% |
0.84 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
№ 70/ 19.04.2010; НСР-7080/09.09.2015 |
02.10.2015 |
|
|
Заличен |
877 |
| C07AA05 |
Propranolol |
Propranolol Actavis |
Tablet |
40 |
mg |
50 |
Актавис EАД, България |
160 |
mg |
- |
5.34 |
0.2688 |
3.36 |
50% |
1.68 |
|
E05.0,E05.1,E05.2,E05.3,E05.4,I10,I11.9,I12.0,I12.9,I13.1,I20.0,I20.8,I45.6,I47.1,I48 |
НСР-7080/09.09.2015 |
02.10.2015 |
|
|
Заличен |
229 |
| C07AA05 |
Propranolol 100% |
C07AA05 Propranolol 100% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| C07AA05 |
Propranolol |
Propranolol Accord |
Film coated tablet |
40 |
mg |
30 |
Accord Healthcare Limited, Обединено Кралство |
160 |
mg |
5.02 |
- |
0.36 |
2.7 |
100% |
2.7 |
|
I10 |
НСР-12460/28.04.2017 |
02.08.2019 |
|
|
Активен |
1766 |
| C07AA05 |
Propranolol |
Propranolol Actavis |
Tablet |
20 |
mg |
50 |
Actavis Group PTC ehf., Исландия |
160 |
mg |
2.58 |
- |
0.36 |
2.25 |
100% |
2.25 |
|
I10 |
HCP-8738/13.04.2016. |
02.08.2019 |
|
|
Активен |
877 |
| C07AA05 |
Propranolol |
Propranolol Actavis |
Tablet |
40 |
mg |
50 |
Актавис EАД, България |
160 |
mg |
4.5 |
- |
0.36 |
4.5 |
100% |
4.5 |
|
I10 |
HCP-8738/13.04.2016. |
02.08.2019 |
|
|
Активен |
229 |
| C07AA05 |
Propranolol |
C07AA05 Propranolol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|